ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,021Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 690

$1.22M Total Retail Price of All Prescriptions

Rank: 35 out of 690

754 Patients Receiving at Least One Drug in Part D
66% Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Mississippi
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

12% of this provider’s 754 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

41% of this provider’s 754 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 1,887 913 283 S3 1 1
OMEPRAZOLE 854 491 151 2 3
POTASSIUM CHLORIDE 737 459 127 3 10
GABAPENTIN 505 279 91 4 9
FUROSEMIDE 500 335 100 5 5
LEVOTHYROXINE SODIUM 493 354 71 6 6
LISINOPRIL 434 275 79 7 4
CLOPIDOGREL 422 297 61 8 16
DIAZEPAM 410 161 61 B 9 85
AMLODIPINE BESYLATE 401 306 76 10 2
NEXIUM 400 254 59 11 26
LORAZEPAM 359 179 78 B 12 41
CARISOPRODOL 353 51 51 R 13 79
METFORMIN HCL 321 183 57 14 8
CLONAZEPAM 306 100 62 B 15 39
METOPROLOL SUCCINATE 296 212 50 16 17
ALPRAZOLAM 295 119 45 B 17 20
METOPROLOL TARTRATE 273 230 43 18 23
AZITHROMYCIN 264 166 180 19 49
TRAMADOL HCL 262 181 73 20 21
PROMETHAZINE HCL 229 80 54 R 21 90
MELOXICAM 216 100 61 22 14
CARVEDILOL 214 181 39 23 15
GLIMEPIRIDE 206 142 35 24 33
SIMVASTATIN 203 168 41 25 7
ZOLPIDEM TARTRATE 201 86 50 26 24
AMITRIPTYLINE HCL 200 94 49 R 27 53
TIZANIDINE HCL 195 61 58 28 63
ATORVASTATIN CALCIUM 187 101 28 29 12
TRIAMTERENE-HCTZ 186 138 33 30 47
CITALOPRAM HBR 178 120 36 31 19
ALLOPURINOL 174 143 29 32 32
LYRICA 165 41 26 33 57
CRESTOR 160 100 23 34 35
RANITIDINE HCL 159 128 40 35 30
WARFARIN SODIUM 153 103 31 36 22
FENTANYL 146 76 23 S2 37 97
TRAZODONE HCL 142 77 25 38 36
PRAVASTATIN SODIUM 139 90 36 39 11
ISOSORBIDE MONONITRATE ER 136 100 28 40 61
CYMBALTA 134 47 24 41 45
NAMENDA 131 131 13 42 29
PROAIR HFA 129 59 35 43 58
FLUTICASONE PROPIONATE 129 73 34 43 46
DOXAZOSIN MESYLATE 128 47 19 45 123
FLUCONAZOLE 124 45 60 46 112
SPIRONOLACTONE 118 78 29 47 63
CLONIDINE HCL 116 70 21 48 38
ATENOLOL 113 71 15 49 31
OXYCODONE HCL-ACETAMINOPHEN 113 37 27 S2 49 92
LOSARTAN POTASSIUM 112 79 16 51 25
PANTOPRAZOLE SODIUM 112 86 24 51 34
CYCLOBENZAPRINE HCL 109 33 30 R 53 60
METFORMIN HCL ER 109 98 19 53 65
ESCITALOPRAM OXALATE 108 66 18 55 51
VENLAFAXINE HCL ER 107 50 12 56 91
DONEPEZIL HCL 104 92 16 57 27
SULFAMETHOXAZOLE-TRIMETHOPRIM 104 72 81 57 73
ACETAMINOPHEN-CODEINE 99 80 26 S3 59 128
TRIAMCINOLONE ACETONIDE 94 53 44 60 173
PREDNISONE 93 69 44 61 55
MONTELUKAST SODIUM 91 33 12 62 44
CIPROFLOXACIN HCL 85 53 70 63 50
MECLIZINE HCL 83 54 37 64 81
MORPHINE SULFATE ER 82 <11 <11 S2 65 146
DEXILANT 81 33 11 66 122
DIGOX 80 60 17 67 87
TAMSULOSIN HCL 79 52 18 68 37
HYDROCHLOROTHIAZIDE 78 67 19 69 13
OXYCONTIN 77 <11 <11 S2 70 241
RAMIPRIL 77 72* 12 70 96
CILOSTAZOL 77 58 17 70 132
SERTRALINE HCL 75 43 16 73 28
PRAMIPEXOLE DIHYDROCHLORIDE 73 42 15 74 189
TERAZOSIN HCL 71 71 12 75 157
SYNTHROID 69 50 15 76 52
IBUPROFEN 69 27 25 76 104
AMOX TR-POTASSIUM CLAVULANATE 69 52 52 76 117
FLUOXETINE HCL 69 31 13 76 71
DILTIAZEM 24HR ER 68 <11 <11 80 198
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 44 16 80 18
NYSTATIN 67 48 35 82 187
DIOVAN 67 <11 <11 82 42
DIGOXIN 67 62* 18 82 167
QUETIAPINE FUMARATE 64 38 11 A 85 54
TOPIRAMATE 63 0 11 86 136
ADVAIR DISKUS 62 24 14 87 94
PAROXETINE HCL 62 <11 <11 87 69
ESTRADIOL 61 19 11 R 89 111
SPIRIVA 61 27 11 89 95
PHENYTOIN SODIUM EXTENDED 59 <11 <11 91 98
PREMARIN 59 <11 <11 R 91 153
ZETIA 58 <11 <11 93 88
BENAZEPRIL HCL 57 <11 <11 94 68
LEVOFLOXACIN 57 41 46 94 77
ALENDRONATE SODIUM 57 <11 <11 94 75
NIFEDIPINE ER 56 <11 <11 97 100
CEFDINIR 55 38 43 98 162
FENOFIBRATE* 54 <11 <11 99 82
AMIODARONE HCL 54 <11 <11 99 139
DETROL LA 53 <11 <11 101 142
LANTUS SOLOSTAR 53 <11 <11 101 130
RISPERIDONE 53 <11 <11 A 101 72
VALACYCLOVIR 51 <11 <11 104 331
OXYCODONE-ACETAMINOPHEN 51 22 29 S2 104 223
PRADAXA 50 <11 <11 106 273
NITROSTAT 50 26 29 106 226
LANTUS 50 <11 13 106 70
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.